Key result
Flow-mediated dilation is primarily mediated by nitric oxide in healthy individuals under standard conditions, but prostacyclin and endothelium-derived hyperpolarizing factor also contribute, particularly in diseased states.
Understanding that flow-mediated dilation is mediated by multiple factors (NO, PGI2, EDHF) is crucial for accurately interpreting endothelial function tests and developing targeted vascular therapies.
Flow-mediated dilation (FMD) is the standard tool used to assess endothelial function. The premise behind the standard FMD test is that it serves as an endothelial-dependant nitric oxide bioassay; however, the endothelium may release additional dilatory molecules which contribute to FMD, most notably prostacyclin and endothelial-derived hyperpolarizing factor. The relative importance of these molecules to the dilatory response may vary substantially among individuals, particularly in response to a number of diseased states. This review discusses how each of these molecules may contribute to vasodilation, and considers the circumstances in which they may vary.
No takes yet. Share an insight, caveat, or question.
Stoner et al. (2012) conducted a review in Endothelial dysfunction. Flow-mediated dilation is primarily mediated by nitric oxide in healthy individuals under standard conditions, but prostacyclin and endothelium-derived hyperpolarizing factor also contribute, particularly in diseased states.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: